Cargando…
Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease
BACKGROUND: It has previously been shown that the Helicobacter pylori (H. pylori)-derived molecule vacuolating cytotoxin A (VacA) could be suitable for the treatment of allergic airway disease. The therapeutic activity of the protein, which acts through modulation of dendritic cells (DC) and regulat...
Autores principales: | Raspe, Jonas, Schmitz, Mona S., Barbet, Kimberly, Caso, Georgia C., Cover, Timothy L., Müller, Anne, Taube, Christian, Reuter, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324189/ https://www.ncbi.nlm.nih.gov/pubmed/37415170 http://dx.doi.org/10.1186/s12931-023-02484-5 |
Ejemplares similares
-
Treatment with Helicobacter pylori-derived VacA attenuates allergic airway disease
por: Reuter, Sebastian, et al.
Publicado: (2023) -
Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin
Publicado: (1996) -
Acid-induced Dissociation of VacA, the Helicobacter pylori Vacuolating Cytotoxin, Reveals Its Pattern of Assembly
por: Cover, Timothy L., et al.
Publicado: (1997) -
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?
por: Imoto, Ichiro, et al.
Publicado: (2022) -
The Versatility of the Helicobacter pylori Vacuolating Cytotoxin VacA in Signal Transduction and Molecular Crosstalk
por: Backert, Steffen, et al.
Publicado: (2010)